Table of Contents
Chapter 1. Global Biochips Market Executive Summary
1.1. Global Biochips Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Application
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Biochips Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Biochips Market Dynamics
3.1. Market Drivers
3.1.1. Increase in Prevalence of Cancer and Genetic Disorders
3.1.2. Rise in Adoption of Personalized Medicine
3.2. Market Challenges
3.2.1. High Cost of Biochip Technology
3.2.2. Lack of Awareness in Emerging Economies
3.3. Market Opportunities
3.3.1. Growing R&D Investments
3.3.2. Expanding Applications in Untapped Markets
3.3.3. Government Funding and Support
Chapter 4. Global Biochips Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Biochips Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. DNA Chip
5.3. Protein Chip
5.4. Lab-on-a-chip
5.5. Others
Chapter 6. Global Biochips Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Biochips Market: Drug Discovery & Development Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.3. Global Biochips Market: Disease Diagnostics Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.4. Genomics
6.5. Proteomics
6.6. Agriculture
6.7. Other Applications
Chapter 7. Global Biochips Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Biotechnology and Pharmaceutical
7.3.Hospitals & Diagnostics Centers
7.4. Academic & Research Institutes
7.5. Other End Users
Chapter 8. Global Biochips Market Size & Forecasts by Region 2022-2032
8.1. North America Biochips Market
8.1.1. U.S. Biochips Market
8.1.1.1. Product breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.2. Canada Biochips Market
8.2. Europe Biochips Market
8.2.1. Germany Biochips Market
8.2.2. France Biochips Market
8.2.3. UK Biochips Market
8.2.4. Italy Biochips Market
8.2.5. Spain Biochips Market
8.2.6. Rest of Europe Biochips Market
8.3. Asia-Pacific Biochips Market
8.3.1. China Biochips Market
8.3.2. Japan Biochips Market
8.3.3. India Biochips Market
8.3.4. Australia Biochips Market
8.3.5. South Korea Biochips Market
8.3.6. Rest of Asia Pacific Biochips Market
8.4. Latin America Biochips Market
8.4.1. Brazil Biochips Market
8.4.2. Mexico Biochips Market
8.4.3. Rest of Latin America Biochips Market
8.5. Middle East and Africa Biochips Market
8.5.1. Saudi Arabia Biochips Market
8.5.2. South Africa Biochips Market
8.5.3. Rest of Middle East and Africa Biochips Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Illumina, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. bioMerieux S.A.
9.3.3. Bio-Rad Laboratories, Inc.
9.3.4. Randox Laboratories Ltd.
9.3.5. Fluidigm Corporation
9.3.6. PerkinElmer, Inc.
9.3.7. QIAGEN N.V.
9.3.8. HORIBA, Ltd.
9.3.9. F. Hoffmann-La Roche Ltd.
9.3.10. Thermo Fisher Scientific Inc.
9.3.11. Micronit Microfluidics BV
9.3.12. OriGene Technologies, Inc.
9.3.13. ANALIS SA/NV
9.3.14. AMS Alliance
9.3.15. Dynamic Biosensors GmbH
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes